Registry of Patients With Hypophosphatasia
NCT02306720 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1571
Last updated 2026-02-27
Summary
In this prospective, observational, long term registry patients of all ages with a diagnosis of hypophosphatasia (HPP) are followed at participating sites in multiple countries.
Conditions
- Hypophosphatasia (HPP)
Sponsors & Collaborators
-
Alexion Pharmaceuticals, Inc.
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-20
- Primary Completion
- 2031-12-31
- Completion
- 2031-12-31
Countries
- United States
- Australia
- Austria
- Canada
- France
- Germany
- Italy
- Poland
- Saudi Arabia
- Spain
- United Kingdom
Study Locations
More Related Trials
-
Treatment of Supine Hypertension in Autonomic Failure
NCT00223717 ·Status: COMPLETED ·Phase: PHASE1
-
Screening for Primary Aldosteronism in a Population of Patients With Hypertension
NCT03105531 ·Status: COMPLETED
-
Essential Hypotension and Allostasis Registry
NCT02018497 ·Status: UNKNOWN
-
Genetic Based Analysis in Hypertensive Patients
NCT04321044 ·Status: COMPLETED ·Phase: NA
-
An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension
NCT03514641 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Monitoring of the Influence of Approved PH-therapies RV-PA Coupling
NCT05935865 ·Status: RECRUITING
-
Phenoxybenzamine Versus Doxazosin in PCC Patients
NCT01379898 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Denervation in Patients With Refractory Hypertension
NCT00753285 ·Status: COMPLETED ·Phase: NA
-
Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism
NCT00004354 ·Status: COMPLETED
-
COMPERA / COMPERA-KIDS
NCT01347216 ·Status: RECRUITING
-
Genetic Predisposition to High Blood Pressure
NCT07181213 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Evaluation of Cerebral Small Vessel Disease in Patient With Primary Aldosteronism
NCT03821571 ·Status: UNKNOWN ·Phase: PHASE1
-
Prognostic Value of Vitamin D and Intact Parathyroid Hormone (iPTH) in Pulmonary Hypertension
NCT06872710 ·Status: NOT_YET_RECRUITING
-
Feasibility Study of the Intensive Systolic Blood Pressure Control
NCT02817503 ·Status: UNKNOWN ·Phase: PHASE4
-
Primary Hyperaldosteronism and Ischemia-reperfusion Injury
NCT01978132 ·Status: COMPLETED ·Phase: NA
-
The Renin-Aldosterone Axis in Postural Tachycardia Syndrome
NCT00962949 ·Status: COMPLETED ·Phase: PHASE1
-
Prediction of Blood Pressure Outcomes Following Renal Denervation (PREDICT-RDN)
NCT06845579 ·Status: RECRUITING ·Phase: NA
-
Reliable Hypertension Diagnosis Based on 24 ABPM
NCT03674918 ·Status: COMPLETED
-
Systemic Arterial Hypertension in Pediatric Age.
NCT06797908 ·Status: RECRUITING
-
A Study in People With Mild Hypertension
NCT00374855 ·Status: COMPLETED ·Phase: PHASE2
-
Institutional Registry of Hyponatremia
NCT01370473 ·Status: COMPLETED
-
Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension
NCT03078244 ·Status: COMPLETED
-
The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.
NCT06208072 ·Status: RECRUITING ·Phase: NA
-
Prognostic Risk of Patients With Essential Hypertension for Cardiovascular Events (PROSPECT)
NCT03708601 ·Status: UNKNOWN
-
Renal Denervation in Patients With Refractory Hypertension
NCT00664638 ·Status: COMPLETED ·Phase: NA